NYLIM
CGEM icon

New York Life Investment Management’s Cullinan Oncology CGEM Stock Holding History

New York Life Investment Management’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-21,250
Closed -$362K – 945
2024
Q1 		$362K Sell
21,250
-12,509
-37% -$193K ﹤0.01% 1164
2023
Q4 		$344K Sell
33,759
-1,045
-3% -$9.26K ﹤0.01% 1133
2023
Q3 		$315K Sell
34,804
-5,483
-14% -$57.1K ﹤0.01% 1110
2023
Q2 		$433K Sell
40,287
-3,618
-8% -$38.4K ﹤0.01% 877
2023
Q1 		$449K Buy
+43,905
New +$484K 0.01% 1139

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

New York Life Investment Management's CGEM Position: Q2 2024 in Review

New York Life Investment Management sold out of Cullinan Oncology (CGEM) in Q2 2024, closing a stake of 21,250 shares — an estimated $362K sold.

New York Life Investment Management first reported a position in CGEM in Q1 2023 and held it in 5 quarters. The position peaked at $449K in Q1 2023. 135 funds tracked by Wall St. Rank hold CGEM as of Q2 2024.

  • New York Life Investment Management reported no remaining Cullinan Oncology position as of Q2 2024 after selling out during the quarter.
  • New York Life Investment Management sold 21,250 Cullinan Oncology shares in Q2 2024, an estimated $362K.
  • New York Life Investment Management first reported a position in Cullinan Oncology in Q1 2023 and held it in 5 quarters.
  • New York Life Investment Management's Cullinan Oncology position peaked at $449K in Q1 2023.
  • 135 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2024.

Based on New York Life Investment Management's 13F filing for Q2 2024, filed 5 Aug 2024.